Literature DB >> 9973406

The mapping of the Lyn kinase binding site of the common beta subunit of IL-3/granulocyte-macrophage colony-stimulating factor/IL-5 receptor.

T Adachi1, K Pazdrak, S Stafford, R Alam.   

Abstract

It has been shown that a membrane-proximal region within common beta (betac) receptor of IL-3/granulocyte-macrophage CSF/IL-5 (amino acids 450-517) is important for Lyn binding. We have shown previously that Lyn kinase is physically associated with the IL-5R betac subunit in unstimulated cells. The result suggests that this association involves binding modules that are not activation or phosphorylation dependent. The objective of this study was to map the exact Lyn binding site on betac. Using overlapping and/or sequential peptides derived from betac 450-517, we narrowed down the Lyn binding site to nine amino acid residues, betac 457-465. The P-->A mutation in this region abrogated the binding to Lyn, indicating a critical role of proline residues. We created a cell-permeable Lyn-binding peptide by N-stearation. This cell-permeable peptide blocked the association of Lyn, but not Jak2 with betac in situ. We also investigated the betac binding site of Lyn kinase. Our results suggest that the N-terminal unique domain of Lyn kinase is important for binding to betac receptor. To our knowledge, this is the first molecular identification of the Lyn binding site of betac receptor. This finding may help develop specific inhibitors of Lyn-coupled signaling pathways.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9973406

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Role of the β Common (βc) Family of Cytokines in Health and Disease.

Authors:  Timothy R Hercus; Winnie L T Kan; Sophie E Broughton; Denis Tvorogov; Hayley S Ramshaw; Jarrod J Sandow; Tracy L Nero; Urmi Dhagat; Emma J Thompson; Karen S Cheung Tung Shing; Duncan R McKenzie; Nicholas J Wilson; Catherine M Owczarek; Gino Vairo; Andrew D Nash; Vinay Tergaonkar; Timothy Hughes; Paul G Ekert; Michael S Samuel; Claudine S Bonder; Michele A Grimbaldeston; Michael W Parker; Angel F Lopez
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

2.  Signaling through a novel domain of gp130 mediates cell proliferation and activation of Hck and Erk kinases.

Authors:  M Schaeffer; M Schneiderbauer; S Weidler; R Tavares; M Warmuth; G de Vos; M Hallek
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

3.  Alternative modes of GM-CSF receptor activation revealed using activated mutants of the common beta-subunit.

Authors:  Michelle Perugini; Anna L Brown; Diana G Salerno; Grant W Booker; Cvetan Stojkoski; Timothy R Hercus; Angel F Lopez; Margaret L Hibbs; Thomas J Gonda; Richard J D'Andrea
Journal:  Blood       Date:  2010-02-19       Impact factor: 22.113

4.  Chemoattractant-induced signaling via the Ras-ERK and PI3K-Akt networks, along with leukotriene C4 release, is dependent on the tyrosine kinase Lyn in IL-5- and IL-3-primed human blood eosinophils.

Authors:  Yiming Zhu; Paul J Bertics
Journal:  J Immunol       Date:  2010-11-24       Impact factor: 5.422

5.  Lipid binding by the Unique and SH3 domains of c-Src suggests a new regulatory mechanism.

Authors:  Yolanda Pérez; Mariano Maffei; Ana Igea; Irene Amata; Margarida Gairí; Angel R Nebreda; Pau Bernadó; Miquel Pons
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

Review 6.  JAK2 activation by growth hormone and other cytokines.

Authors:  Michael J Waters; Andrew J Brooks
Journal:  Biochem J       Date:  2015-02-15       Impact factor: 3.857

Review 7.  Advances and challenges in targeting IRF5, a key regulator of inflammation.

Authors:  Hannah Almuttaqi; Irina A Udalova
Journal:  FEBS J       Date:  2018-09-21       Impact factor: 5.542

8.  The IL-3, IL-5, and GM-CSF common receptor beta chain mediates oncogenic activity of FLT3-ITD-positive AML.

Authors:  Anne Charlet; Max Kappenstein; Christoph Rummelt; Nikolas von Bubnoff; Philip Keye; Kathrin Kläsener; Cornelia Endres; Teresa Poggio; Sivahari P Gorantla; Stefanie Kreutmair; Jana Sänger; Anna L Illert; Cornelius Miething; Michael Reth; Justus Duyster
Journal:  Leukemia       Date:  2021-11-08       Impact factor: 11.528

9.  Directed Evolution of a Highly Specific FN3 Monobody to the SH3 Domain of Human Lyn Tyrosine Kinase.

Authors:  Renhua Huang; Pete Fang; Zengping Hao; Brian K Kay
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.